ReviewJournal of intensive care2026
Computed tomography in ARDS, from morphological insights to AI-powered multi-modal analysis: a narrative review.
Review in Journal of intensive care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundAcute respiratory distress syndrome (ARDS) is a critical clinical condition characterized by acute respiratory failure and high mortality. It poses considerable challenges in both diagnosis and management. Imaging constitutes a central element of the conceptual framework for ARDS, with computed tomography (CT) being an essential technical tool for studying the morphological and pathological mechanisms of lung tissue in ARDS. MAIN TEXT: CT imaging has provided profound insights into the respiratory mechanics in ARDS and has informed the optimization of ventilation strategies. It is widely used to characterize the typical pathophysiological manifestations of ARDS in the lungs and can quantify the distribution of ventilation, perfusion, and pulmonary edema. Moreover, CT-based morphological classification of ARDS constitutes a significant component of ARDS subphenotypes research. However, given the heterogeneity in both its diagnosis and response to treatment, a single assessment model is insufficient to meet the management needs of patients with ARDS. The widespread application of artificial intelligence (AI) has greatly facilitated the quantitative analysis of CT imaging, enabling the integration of multidimensional data, such as CT imaging, pulmonary functional data, and laboratory tests.
conclusionThis narrative review adopts a CT-centric viewpoint, delineating the progressive shift in the diagnosis, phenotyping, and management of ARDS from qualitative to quantitative analysis and from unimodal to multimodal evaluation, propelled by ongoing advances in AI. Looking forward, CT-based multimodal fusion analysis holds promise for identifying more precise therapeutic biomarkers and advancing the development of individualized treatment strategies for ARDS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.